| Primary |
| Dyspepsia |
71.0% |
| Gastrooesophageal Reflux Disease |
8.1% |
| Hypertension |
3.3% |
| Blood Cholesterol Increased |
2.4% |
| Hypothyroidism |
1.7% |
| Diabetes Mellitus |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Hypersensitivity |
1.3% |
| Asthma |
1.1% |
| Urticaria |
1.1% |
| Cardiac Disorder |
0.9% |
| Diarrhoea |
0.9% |
| Gastritis |
0.9% |
| Hiatus Hernia |
0.9% |
| Anxiety |
0.7% |
| Flatulence |
0.7% |
| Heart Rate Irregular |
0.7% |
| Insomnia |
0.7% |
| Arthritis |
0.4% |
| Fluid Retention |
0.4% |
|
| Drug Ineffective |
27.6% |
| Dyspepsia |
12.2% |
| Off Label Use |
8.3% |
| Drug Screen Positive |
6.1% |
| Flatulence |
5.0% |
| Overdose |
4.4% |
| Throat Irritation |
3.9% |
| Vomiting |
3.9% |
| Dyspnoea |
3.3% |
| Incorrect Drug Administration Duration |
3.3% |
| Nausea |
3.3% |
| Accidental Exposure To Product By Child |
2.8% |
| Urticaria |
2.8% |
| Headache |
2.2% |
| Pain In Extremity |
2.2% |
| Rash |
2.2% |
| Abdominal Pain Upper |
1.7% |
| Accidental Overdose |
1.7% |
| Blood Glucose Increased |
1.7% |
| Chest Pain |
1.7% |
|
| Secondary |
| Dyspepsia |
77.6% |
| Gastrooesophageal Reflux Disease |
4.0% |
| Hypertension |
2.8% |
| Atrial Fibrillation |
2.2% |
| Diabetes Mellitus |
1.6% |
| Blood Cholesterol Increased |
1.2% |
| Hiatus Hernia |
1.2% |
| Hypothyroidism |
1.2% |
| Pain |
1.2% |
| Anxiety |
0.6% |
| Arthritis |
0.6% |
| Blood Pressure Abnormal |
0.6% |
| Cardiac Disorder |
0.6% |
| Cardiac Failure Congestive |
0.6% |
| Flatulence |
0.6% |
| Gastric Ulcer |
0.6% |
| Gastritis |
0.6% |
| Heart Rate Irregular |
0.6% |
| Inflammation |
0.6% |
| Oedema Peripheral |
0.6% |
|
| Drug Ineffective |
21.1% |
| Dyspepsia |
11.1% |
| Off Label Use |
6.7% |
| Flatulence |
5.6% |
| Incorrect Drug Administration Duration |
5.6% |
| Overdose |
5.6% |
| Drug Screen Positive |
4.4% |
| Intentional Overdose |
4.4% |
| Pain In Extremity |
4.4% |
| Accidental Overdose |
3.3% |
| Dyspnoea |
3.3% |
| Hyperhidrosis |
3.3% |
| Nausea |
3.3% |
| Throat Irritation |
3.3% |
| Vomiting |
3.3% |
| Abdominal Pain Upper |
2.2% |
| Blood Glucose Increased |
2.2% |
| Chest Pain |
2.2% |
| Headache |
2.2% |
| Insomnia |
2.2% |
|
| Concomitant |
| Plasma Cell Myeloma |
15.4% |
| Chronic Myeloid Leukaemia |
8.8% |
| Osteoporosis |
8.8% |
| Product Used For Unknown Indication |
8.8% |
| Multiple Sclerosis |
7.7% |
| Precursor T-lymphoblastic Lymphoma/leukaemia |
7.7% |
| Hereditary Angioedema |
6.6% |
| Prostate Cancer Metastatic |
5.5% |
| Relapsing-remitting Multiple Sclerosis |
4.4% |
| Immunodeficiency Common Variable |
3.3% |
| Thyroid Cancer |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Type Iia Hyperlipidaemia |
3.3% |
| Age-related Macular Degeneration |
2.2% |
| Application Site Anaesthesia |
2.2% |
| Colon Cancer |
2.2% |
| Nausea |
2.2% |
| Secondary Immunodeficiency |
2.2% |
| 5Q Minus Syndrome |
1.1% |
| Alpha-1 Anti-trypsin Deficiency |
1.1% |
|
| Vomiting |
14.3% |
| White Blood Cell Count Decreased |
10.7% |
| Nausea |
8.9% |
| Headache |
7.1% |
| Death |
5.4% |
| Pyrexia |
5.4% |
| Vision Blurred |
5.4% |
| Hypertension |
3.6% |
| Insomnia |
3.6% |
| Neuropathy Peripheral |
3.6% |
| Pneumonia |
3.6% |
| Rash |
3.6% |
| Renal Failure |
3.6% |
| Stress Fracture |
3.6% |
| Vitreous Floaters |
3.6% |
| Weight Decreased |
3.6% |
| Weight Increased |
3.6% |
| Yawning |
3.6% |
| Aspartate Aminotransferase Increased |
1.8% |
| Bacteraemia |
1.8% |
|
